Resistance to echinocandin-class antifungal drugs. - Test2 - elhamkhani - TriplyDB

Resistance to echinocandin-class antifungal drugs.

Resistance to echinocandin-class antifungal drugs.

http://www.wikidata.org/entity/Q36849595

about

Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases In Vivo Anti-Candida Activity of Phenolic Extracts and Compounds: Future Perspectives Focusing on Effective Clinical Interventions Mechanisms of Candida biofilm drug resistance pH signaling in human fungal pathogens: a new target for antifungal strategies Coping with stress and the emergence of multidrug resistance in fungi Genetic and structural validation ofAspergillus fumigatus UDP-N-acetylglucosamine pyrophosphorylase as an antifungal target Cell wall integrity is linked to mitochondria and phospholipid homeostasis in Candida albicans through the activity of the post-transcriptional regulator Ccr4-Pop2.Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata A phenylalanine to serine substitution within an O-protein mannosyltransferase led to strong resistance to PMT-inhibitors in Pichia pastoris Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes Echinocandin resistance: an emerging clinical problem?Metal Chelation as a Powerful Strategy to Probe Cellular Circuitry Governing Fungal Drug Resistance and Morphogenesis High-throughput screen for identifying small molecules that target fungal zinc homeostasis Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis Siderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal therapy.Genetic Basis of Antifungal Drug Resistance Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.Modulation of Alternaria infectoria cell wall chitin and glucan synthesis by cell wall synthase inhibitors.Distinct roles of cell wall biogenesis in yeast morphogenesis as revealed by multivariate analysis of high-dimensional morphometric data Micafungin use in children.Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites.Overcoming antifungal resistance.Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.Oropharyngeal candidiasis in the era of antiretroviral therapy Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats.Candida infections and their prevention.Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.Novel FKS mutations associated with echinocandin resistance in Candida species.Bridging the Gap to Non-toxic Fungal Control: Lupinus-Derived Blad-Containing Oligomer as a Novel Candidate to Combat Human Pathogenic Fungi.Breakthrough invasive Candida glabrata in patients on micafungin: a novel FKS gene conversion correlated with sequential elevation of MIC.Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy Breakthrough invasive candidiasis in patients on micafungin.Echinocandins: the newest class of antifungals.Intestinal resident yeast Candida glabrata requires Cyb2p-mediated lactate assimilation to adapt in mouse intestine Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr

P2860

Q26774692-204A82B3-3C2E-444C-B5E1-121BF85627AE Q26783986-208318E0-5167-4846-9CF8-8A3A1B34CFAA Q26827521-DE7D99BC-3620-45EA-B311-58898209BE31 Q26830123-3273C9E0-A214-434A-ACAF-466E864384B0 Q27025256-AC988E2A-74DF-4B48-B56A-9085D25E360C Q27678557-98355A59-16BB-4EBB-BB04-90CDBDEC1017 Q27936692-B4EE39D4-88A8-4C70-A97F-C2E8E9CE8DCE Q28388806-71753109-3CD2-4BB2-BD38-8337E63E0D3E Q28475818-2547094B-AF29-4E5D-BE1B-F86E606D9F03 Q28483590-C97A76A5-E6FC-40A3-84C2-608C0B5B6720 Q28483785-04AD1B30-F01D-4D1C-9E02-BCF89C92846B Q28487786-C40424D6-0F2D-4736-88C6-3F8F59D0350B Q28539874-68FF2995-BDAC-4C1C-B589-2A70F8DB7D40 Q28544739-187C9785-3E26-4C43-ACC3-37EC253CF291 Q28554456-4E89B8BE-866D-409E-AEA5-EF6108C3F7EB Q28744422-CECC2269-B187-4B74-8119-0A0ECBA43500 Q28818603-E41C32CB-A570-4922-9198-763F6596EEDE Q30243906-8C6B71A2-699A-4101-8EDC-734C494AEA09 Q30434904-CD553C7B-2EBF-4346-85ED-2C43ED01777A Q30570494-F8DA5219-A931-4FC8-B98C-2FA588FDF7AC Q30576509-1FD940E7-BCBB-48E3-B127-2B18E5239BF8 Q30698272-EF4E50BD-66F5-44DA-8573-429B95C75917 Q33397111-E4E8A8CA-952B-4449-86A2-11D606BACC25 Q33490772-200D281E-5EF8-47AD-8BC9-4403D6E7ECC1 Q33532335-958D1E92-1F72-4BA6-86C8-12522ACFFC90 Q33643814-1F83C65F-28D6-4D76-BC1D-A168F0F41301 Q33651853-D33972AC-74FE-44ED-BF08-C72301EB718F Q33676430-EAAFD110-0F18-45C9-811D-B2F8DA586ADD Q33746435-760AB6C9-C9B6-48CC-A600-C87CF1B1728F Q33757912-5878D09A-5F77-4356-8667-49A1FE78FA65 Q33775256-C913B1BA-5D19-4E5F-9147-74C04EE152D5 Q33798606-3E48BA1B-21C3-4A93-B3BE-81DC970FF37D Q33826330-5A1FF6B5-3557-47BA-BE0B-2A02AA9B98FE Q33843321-7B8D077E-A332-4F5F-8A9F-4A095ECFA803 Q33900103-C48F5324-C92C-49CD-84FC-0F5376A70CD3 Q33940382-B7031B11-E6B9-4517-B2C8-5C2299F7E596 Q33963538-E3010C67-C72A-4B0C-BC29-785E2E816084 Q34019188-8159C4AD-6267-4555-9D54-C80A37089BFF Q34024025-92AC10AA-573C-4FCC-85ED-85C509A421DC Q34057480-668F65D1-1482-4A26-BD06-C91FECF99B6E

P2860

Resistance to echinocandin-class antifungal drugs.

http://www.wikidata.org/entity/Q36849595

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Resistance to echinocandin-class antifungal drugs.

@en

type

label

Resistance to echinocandin-class antifungal drugs.

@en

prefLabel

Resistance to echinocandin-class antifungal drugs.

@en

P1433

Q36849595-6C70B080-9BB3-4A12-9BF6-8ADB6FA3D3EB

P1476

Q36849595-8DE42CC5-D8D5-46CD-84A6-995E2D612CC6

P2093

Q36849595-B79762E9-EA18-4E92-A2AA-A5BDCDEE6715

P2860

Q36849595-05D43C8F-AFFE-40E6-B6B7-25C44983A3D8

Q36849595-0851EEF8-D388-417F-8106-D37A5EC0D6F7

Q36849595-0E263D43-373A-4A46-AAE0-CDA85D5ED24A

Q36849595-0F6009C6-1251-465D-A797-B7F994EE6EA3

Q36849595-0FAF50A4-F8EA-470A-8FDE-DF3B73D435B2

Q36849595-130766BE-D958-4A44-A697-01EA9CC28E8D

Q36849595-1B883EC0-BFF1-4EC9-A90C-42B2DDE18844

Q36849595-21AFA1F6-D63E-410C-8369-886DA38EB847

Q36849595-233E28B6-1B30-4C9A-9E01-5C279220C915

Q36849595-24762B28-6CBD-4FB3-AB2F-00F671850DFE

P304

Q36849595-F2C41E21-E3F8-4F49-BDD8-473511B12418

P31

Q36849595-3C277930-5A25-49F6-9498-553B0F7ACAB6

P356

Q36849595-3E6E3E84-D5E6-4B32-9C30-2220DBA4185A

P433

Q36849595-E0324AD5-F743-4D76-A71D-572AF77746EB

P478

Q36849595-B6831245-EF88-4079-A678-A46B32AD7AF5

P577

Q36849595-A87A8981-9E54-4AF1-9731-348B3287BA86

P5875

Q36849595-9E19E6B8-D2F8-47C9-BCE0-AFE440C61B36

P698

Q36849595-864B4926-4E76-43D5-94EF-8A871B8F53DB

P932

Q36849595-83C927DC-68AB-4847-9EE3-745EE1A93D7B

P356

J.DRUP.2007.04.002

P1433

Drug Resistance Updates

P1476

Resistance to echinocandin-class antifungal drugs.

@en

P2093

David S Perlin

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.

In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole

Cell wall assembly in Saccharomyces cerevisiae

Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin

Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis

An interactional network of genes involved in chitin synthesis in Saccharomyces cerevisiae

Higher plant glycosyltransferases

Movement of yeast 1,3-beta-glucan synthase is essential for uniform cell wall synthesis.

Regulation of the Saccharomyces cerevisiae Slt2 kinase pathway by the stress-inducible Sdp1 dual specificity phosphatase.

In vitro activity of 1,3-beta-D-glucan synthase requires the GTP-binding protein Rho1.

P304

121-130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUP.2007.04.002

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6266767

http://www.w3.org/2001/XMLSchema#string

P698

17569573

http://www.w3.org/2001/XMLSchema#string

P932

2696280

http://www.w3.org/2001/XMLSchema#string